Analyst stock forecast
Neurogene Forecast: $80.43 Analyst Target
Direct answer
Neurogene's average price target is $80.43.
The target implies +203.8% from the recorded current price, and the consensus rating is none.
The low target implies +73.8%, the high target implies +527.1%, and the range spans 453.3% of the current price.
Forecast evidence checked October 6, 2026.
Get free Neurogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $26.47
- Average price target
- $80.43
- High price target
- $166.00
- Low price target
- $46.00
- Low target gap
- +73.8%
- Target upside
- +203.8%
- High target gap
- +527.1%
- Target range width
- 453.3%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- October 6, 2026
- Valid through
- October 13, 2026
Explore related company data
Read the frequently asked questions.
What is Neurogene's average price target?
Neurogene's verified average price target is $80.43. The target range is $46.00 to $166.00.
How far are Neurogene's low and high targets from the recorded price?
The low target implies +73.8%, while the high target implies +527.1%.
How many analysts are included in Neurogene's consensus?
The verified consensus includes 7 analysts.
How is Neurogene's target upside or downside calculated?
The average target of $80.43 is divided by the recorded price of $26.47, then one is subtracted to produce +203.8%. This does not guarantee a future return.
When was Neurogene's analyst forecast verified?
The data was verified on 2026-10-06. The dataset is valid through 2026-10-13.